Investing in biotech offers high upside but comes with significant risks, especially with volatile stock movements and binary ...

Pacira BioSciences markets and sells EXPAREL, a non-opioid pain relief therapy. The drug drives revenues of >$500m per annum, ...

Bio-Rad is filing fewer patents year after year, which suggests that it is struggling to innovate and develop new products and services. The company is lagging its peers with a negative ROE, and net ...

American Airlines has a challenging debt load that is nearly impossible to carry with the free cash flow generation. Learn ...

J.P. Morgan analysts updated their “Analyst Focus List” which targets growth, income, value, and short ideas. Analysts added ...

Financial writer discusses potential impact of La Niña on natural gas and heating oil spreads, South American crops, and ...

Google faces regulatory challenges across both sides of the Atlantic, which is unlikely to disappear soon. Click here to read ...

ASML faces a slowdown in Capex, but its long-term prospects are strong. See why ASML stock's 40% drop makes it a compelling ...

Bright Scholar Education Holdings Limited ( NYSE: BEDU) Q4 2024 Earnings Conference Call November 25, 2024 7:00 AM ET Andrea Guo - IR, Piacente Financial Communications Ruolei Niu - CEO Zhang Hui - ...

Spirit Airlines' bankruptcy plan benefits debt holders, not the airline's future. See why SAVEQ stock investors will see no ...

Opendoor's growth stagnated despite interest rate cuts. Learn why OPEN stock is struggling amid low home sales and housing ...

TELUS International has seen its stock plummet more than 90% from its highs amid poor operating results. Learn more about ...